Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedUpdated the ClinicalTrials.gov page revision indicator from v3.5.2 to v3.5.3, reflecting a platform/software version change rather than a change to the study details.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No changes to study details or page content are introduced.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.4.3 added to the site; it replaces the previous v3.4.2.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; no study content, eligibility criteria, or user-facing information appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check97 days agoChange DetectedThe page shows a minor site version update: Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.